cells that causes virtually no side effects. Both CD22 immunotoxin constructs (the IgG-dgA and the been produced in gram quantities in a GLP-P3 laboratory at the University of Texas. These endotoxin-free, reagents have received FDA approval for phase I clinical trials. In these trials, toxicity, its, antibody response and efficacy are being determined. Our findings in the first 20 patients will be
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.